Marketplace
For Industry Partners
For Innovators
Contact sales
Sign in
Join now
AB
Anthony Berardi
Founder, CEO
Citrimer
Publications
7
Funding
0
Patents
0
A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain
Plos one 16 (10), e0252558, 2021
Enzyme‐Based Synthetic Protein Nanoparticles as Colloidal Antioxidants
Advanced Therapeutics 6 (11), 2300007, 2023
Synthetic Protein Nanoparticles via Photoreactive Electrohydrodynamic Jetting
Macromolecular Rapid Communications 45 (21), 2400349, 2024
Self-Reporting Therapeutic Protein Nanoparticles
ACS Applied Materials & Interfaces 16 (33), 43350-43363, 2024
Photo‐Arbuzov Reactions as a Broadly Applicable Surface Modification Strategy
Advanced Functional Materials, 2403408, 2024
Heterobifunctional RAFT polymers enable orthogonal end group chemistry
2022 Materials Research Society Spring Meeting, 2022
Toward novel nanomaterials for 19F magnetic resonance imaging (MRI) contrast agents
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 254, 2017
AB
Anthony Berardi
Founder, CEO
Citrimer
Work experience
Citrimer
Founder, CEO
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Open to opportunities in
Chemical Engineering
Chemistry
Nanomaterials
Organic Chemistry
Polymer Behavior
Last updated Feb 2025
Report Error
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
Subscribe
Company
About
Blog
Careers
Halo Awards
Support
FAQs
Help center
Feature requests
Contact support
Sponsors
Customer stories
Privacy Policy
Terms of Service
© 2026 Halo Cures, Inc.